[1. Bioparadigms [displayed 1 September 2015]. Available at http://www.bioparadigms.org/slc/menu.asp]Search in Google Scholar
[2. Hediger MA, guest editor. Special issue: The ABCs of solute carriers: physiological, pathological, and therapeutic implications of human membrane transport proteins. Pflügers Arch - Eur J Physiol 2004;447.10.1007/s00424-003-1192-y14624363]Search in Google Scholar
[3. Srimaroeng C, Perry JL, Pritchard JB. Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica 2008;38:889-935. doi: 10.1080/ 0049825080192743510.1080/00498250801927435264406618668434]Search in Google Scholar
[4. Fromm MF, Kim RB, editors. Drug Transporters. Handbook of Experimental Pharmacology 201. Berlin, Heidelberg: Springer-Verlag; 2011.10.1007/978-3-642-14541-4]Search in Google Scholar
[5. Koepsell H. Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol Sci 2004;25:375-81. PMID: 1521998010.1016/j.tips.2004.05.00515219980]Search in Google Scholar
[6. Rizwan AN, Burckhardt G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharmaceut Res 2007;24:450-70. doi: 10.1007/s11095-006-9181-410.1007/s11095-006-9181-417245646]Search in Google Scholar
[7. Koepsell H. The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 2013;34:413-35. doi: 10.1016/j.mam.2012.10.01010.1016/j.mam.2012.10.01023506881]Search in Google Scholar
[8. Omote H, Hiasa M, Matsumoto T, Otsuka M, Moriyama Y. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol Sci 2006;27:587-93. PMID: 1699662110.1016/j.tips.2006.09.00116996621]Search in Google Scholar
[9. Chen L-Q, Cheung LS, Feng L, Tanner W, Frommer WB. Transport of sugars. Annu Rev Biochem 2015;84:865-94. doi: 10.1146/annurev-biochem-060614-03390410.1146/annurev-biochem-060614-03390425747398]Search in Google Scholar
[10. Poulsen SB, Fenton RA, Rieg T. Sodium-glucose cotransport. Curr Opin Nephrol Hypertens 2015;24:463-9. doi: 10.1097/ MNH.000000000000015210.1097/MNH.0000000000000152536402826125647]Search in Google Scholar
[11. Vrhovac I, Balen Eror D, Klessen D, Burger C, Breljak D, Kraus O, Radović N, Jadrijević S, Aleksic I, Walles T, Sauvant C, Sabolić I, Koepsell H. Locations of Na+-Dglucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung and heart. Pflügers Arch - Eur J Physiol 2015;467:1881-98. doi: 10.1007/s00424-014-1619-710.1007/s00424-014-1619-725304002]Search in Google Scholar
[12. Stieger B, Higgins CF, guest editors. Twenty years of ABC transporters. Pflügers Arch - Eur J Physiol 2007;453.10.1007/s00424-006-0159-1]Search in Google Scholar
[13. Endres CJ, Hsiao P, Chung FC, Unadkat JD. The role of transporters in drug interactions. Eur J Pharmaceut Sci 2006;27:501-17. doi: 10.1016/j.ejps.2005.11.00210.1016/j.ejps.2005.11.002]Search in Google Scholar
[14. König J, Müller F, Fromm MF. Transporters and drug-drug interactions: Important determinants of drug disposition and effects. Pharmacol Rev 2013;65:944-66. doi: 10.1124/ pr.113.00751810.1124/pr.113.007518]Search in Google Scholar
[15. Ho RH, Kim RB. Transporters and drug therapy: Implications for drug disposition and disease. Clin Pharmacol Therapeut 2005;78:260-77. doi: 10.1016/j.clpt.2005.05.01110.1016/j.clpt.2005.05.011]Search in Google Scholar
[16. Sabolić I, Breljak D, Ljubojević M, Brzica H. Are mice, rats, and rabbits good models for physiological, pharmacological and toxicological studies in humans? Period biol 2011;113:7-16.]Search in Google Scholar
[17. van der Oost R, Beyer J, Vermeulen NPE. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ Toxicol Pharmacol 2003;13:57-149. doi: 10.1016/ S1382-6689(02)00126-610.1016/S1382-6689(02)00126-6]Search in Google Scholar
[18. Epel D, Stevenson CN, MacManus-Spencer LA, Luckenbach T, Hamdoun A, Smital T. Efflux transporters: newly appreciated roles in protection against pollutants. Environ Sci Technol 2008;42:3914-20. doi: 10.1021/es087187v10.1021/es087187v316078118589945]Search in Google Scholar
[19. Luckenbach T, Fischer S, Sturm A. Current advances on ABC drug transporters in fish. Comp Biochem Physiol C - Toxicol Pharmacol 2014;165:28-52. doi: 10.1016/j.cbpc.2014.05.00210.1016/j.cbpc.2014.05.00224858718]Search in Google Scholar
[20. Smital T, Luckenbach T, Sauerborn R, Hamdoun AM, Vega RL, Epel D. Emerging contaminants - pesticides, PPCPs, microbial degradation products and natural substances as inhibitors of multixenobiotic defense in aquatic organisms. Mut Res 2004;552:101-17. doi: 10.1016/j.mrfmmm. 2004.06.006]Search in Google Scholar
[21. Žaja R, Terzić S, Senta I, Lončar J, Popović M, Ahel M, Smital T. Identification of P-glycoprotein (P-gp, Abcb1) inhibitors in contaminated freshwater sediments. Environ Sci Technol 2013;47:4813-21. doi: 10.1021/es400334t10.1021/es400334t23570494]Search in Google Scholar
[22. Popović M, Žaja R, Smital T. Organic anion transporting polypeptides (OATP) in zebrafish (Danio rerio): phylogenetic analysis and tissue distribution. Comp Biochem Physiol A - Mol Integr Physiol 2010;155:327-35. doi: 10.1016/j. cbpa.2009.11.011]Search in Google Scholar
[23. Popović M, Žaja R, Fent K, Smital T. Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion transporting polypeptide. J Biol Chem 2013;288:33894-911. doi: 10.1074/jbc.M113.51850610.1074/jbc.M113.518506383713124126916]Search in Google Scholar
[24. Popović M, Žaja R, Fent K, Smital T. Interaction of environmental contaminants with zebrafish uptake transporter Oatp1d1 (Slco1d1). Toxicol Appl Pharmacol 2014;280:149-58. doi: 10.1016/j.taap.2014.07.01510.1016/j.taap.2014.07.01525088042]Search in Google Scholar